Port delivery system (PDS) intravitreal implants — the refillable, permanent titanium ports with intravitreal catheters enabling continuous anti-VEGF drug delivery over 6–12 months with office-based refills — represent the fastest-transforming delivery modality in the global retinal therapeutics landscape, with the Ocular Drug Delivery Market reflecting PDS technology as the...

Suprachoroidal injection technology — the microneedle-based delivery of therapeutic agents into the potential space between choroid and sclera, enabling targeted macular and retinal drug deposition while sparing vitreous and anterior segment structures representing the fastest-growing innovation in the global ocular drug delivery market — creates the most anatomically precise market...